Oncogenes in Thyroid Cancer

作者: Katherine B. Weber , Michael T. McDermott

DOI: 10.1007/978-1-59259-995-0_5

关键词:

摘要: At the time of conception, human organism is a single cell zygote. During course development into an adult, this expands complex mass approximately 100 trillion cells, with enormous variety shapes, sizes, and functions. Normal tissue growth require prolific division, exquisitely regulated differentiation, appropriately timed death or apoptosis. Neoplastic transformation generally occurs when abnormal regulatory mechanisms promote excessive impaired and/or failure In most tumor types, aberrant control originates at genetic level.

参考文章(140)
D Wynford-Thomas, F S Wyllie, N R Lemoine, E D Williams, B Stringer, E S Mayall, M Goyns, High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene. ,vol. 4, pp. 159- 164 ,(1989)
S. Sheu, R. Görges, K. Mann, S. Bokler, A. Frilling, K. W. Schmid, F. Otterbach, L. S. Freudenberg, Prognostic value of c-erbB-2 expression in papillary thyroid carcinoma Nuklearmedizin-nuclear Medicine. ,vol. 44, pp. 179- 184 ,(2005) , 10.1055/S-0038-1625202
I. Bongarzone, C. Lanzi, A. Greco, S. Pagliardini, G. Della Porta, M. A. Pierotti, TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene. ,vol. 7, pp. 237- 242 ,(1992)
D. Wynford-Thomas, F. S. Wyllie, N. R. Lemoine, E. D. Williams, R. A. Padua, C. J. Farr, D. Hughes, V. Thurston, E. S. Mayall, Activated ras oncogenes in human thyroid cancers. Cancer Research. ,vol. 48, pp. 4459- 4463 ,(1988)
M S Greenblatt, W P Bennett, M Hollstein, C C Harris, Mutations in the p53 Tumor Suppressor Gene: Clues to Cancer Etiology and Molecular Pathogenesis Cancer Research. ,vol. 54, pp. 4855- 4878 ,(1994)
Elena Arighi, Bruce A J Ponder, Piera Mondellini, Italia Bongarzone, Lucio Scopsi, Renata Bocciardi, Marco A. Pierotti, Maria Grazia Borrello, Angela Greco, Charis Eng, Claudia Miranda, Maria J. Lorenzo, Darrin P. Smith, Luisella Alberti, Barbara Pasini, Giovanni Romeo, RET activation by germline MEN2A and MEN2B mutations. Oncogene. ,vol. 11, pp. 2419- 2427 ,(1995)
Todd G Kroll, Pasha Sarraf, Lorenza Pecciarini, Chang-Jie Chen, Elisabetta Mueller, Bruce M Spiegelman, Jonathan A Fletcher, PAX8-PPARγ1 Fusion in Oncogene Human Thyroid Carcinoma Science. ,vol. 289, pp. 1357- 1360 ,(2000) , 10.1126/SCIENCE.289.5483.1357
Kenneth B. Ain, Paolo Gattuso, Xiulong Xu, Richard A. Prinz, Roderick M. Quiros, High Prevalence of BRAF Gene Mutation in Papillary Thyroid Carcinomas and Thyroid Tumor Cell Lines Cancer Research. ,vol. 63, pp. 4561- 4567 ,(2003)
Edna T Kimura, Marina N Nikiforova, Zhaowen Zhu, Jeffrey A Knauf, Yuri E Nikiforov, James A Fagin, None, High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research. ,vol. 63, pp. 1454- 1457 ,(2003)
Marcel Dorée, Simon Galas, The cyclin-dependent protein kinases and the control of cell division. The FASEB Journal. ,vol. 8, pp. 1114- 1121 ,(1994) , 10.1096/FASEBJ.8.14.7958616